EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial peptide Hs02 with rapid bactericidal, anti-biofilm, and anti-inflammatory activity against carbapenem-resistant Klebsiella pneumoniae and Escherichia coli

Deyi Zhao iD, Miran Tang, Panjie Hu, Xiaowei Hu, Weijun Chen, Zhexiao Ma, Huanchang Chen, Haifeng Liu, Jianming Cao iD, Tieli Zhou iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01050-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Deyi Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affilia…. Hauptthemen laut MEDLINE: Biofilms, Klebsiella pneumoniae, Escherichia coli, Anti-Inflammatory Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Klebsiella pneumoniae (CRKP) and Escherichia coli (CREC) are frequently detected in clinical settings, restricting the use of carbapenems. Therefore, there is an urgent need for new antimicrobial strategies to address infections caused by CRKP and CREC. This study investigated the antibacterial, anti-biofilm, and anti-inflammatory effects of the cationic antimicrobial peptide Hs02, along with its potential antimicrobial mechanisms against CRKP and CREC. The results revealed that Hs02 had a low minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against CRKP and CREC, effectively eliminating the bacteria within 30 min. Moreover, Hs02 significantly prevents biofilm formation and disrupts the established biofilms. Further mechanistic studies demonstrated that Hs02 specifically targeted and bound to bacterial outer membrane lipopolysaccharides (LPS), disrupted membrane permeability and integrity, which led to intracellular reactive oxygen species (ROS) accumulation. Furthermore, Hs02 neutralized LPS, thereby suppressing the production of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in murine macrophage RAW 264.7 cells. In vitro , hemolysis and cytotoxicity assays confirmed Hs02’s safety at the tested concentrations and proved that Hs02 improved the survival rate of Galleria mellonella larvae. In conclusion, the findings suggest that Hs02’s interaction with LPS and the resulting disruption of membrane integrity may be key factors driving its rapid bactericidal and anti-inflammatory effects. IMPORTANCE Eukaryotic antimicrobial peptides are typically amphipathic peptides consisting of approximately 50 amino acids. Many macromolecular proteins in our body contain polypeptide sequences that show characteristics similar to those of antimicrobial peptides. The present research highlights a gap in the current literature regarding the mechanisms by which the intragenic antimicrobial peptide Hs02, derived from human proteins, exerts its rapid bactericidal and anti-inflammatory effects. The findings demonstrate that lipopolysaccharide (LPS) is a key target of Hs02’s antimicrobial activity and that its ability to neutralize LPS is crucial for its anti-inflammatory effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsKlebsiella pneumoniaeEscherichia coliAnti-Inflammatory AgentsAnti-Bacterial AgentsMicrobial Sensitivity TestsAntimicrobial PeptidesCarbapenemsAnimalsMiceRAW 264.7 CellsLipopolysaccharidesKlebsiella InfectionsAntimicrobial Cationic PeptidesMothsHumansCarbapenem-Resistant Enterobacteriaceae

Stichwörter der Autor:innen

Hs02LPS neutralizationantimicrobial peptidescarbapenem-resistance

Substanzen

Anti-Inflammatory AgentsAnti-Bacterial AgentsAntimicrobial PeptidesCarbapenemsLipopolysaccharidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Deyi Zhao, Jianming Cao, Tieli Zhou

Zitieren

APA

Zhao, D., Tang, M., Hu, P., Hu, X., Chen, W., Ma, Z., Chen, H., Liu, H., Cao, J., & Zhou, T. (2025). Antimicrobial peptide Hs02 with rapid bactericidal, anti-biofilm, and anti-inflammatory activity against carbapenem-resistant Klebsiella pneumoniae and Escherichia coli. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01050-24

Vancouver

Zhao D, Tang M, Hu P, Hu X, Chen W, Ma Z, et al. Antimicrobial peptide Hs02 with rapid bactericidal, anti-biofilm, and anti-inflammatory activity against carbapenem-resistant Klebsiella pneumoniae and Escherichia coli. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01050-24

BibTeX
@article{Zhao2025,
  author = {Zhao, Deyi and Tang, Miran and Hu, Panjie and Hu, Xiaowei and Chen, Weijun and Ma, Zhexiao and Chen, Huanchang and Liu, Haifeng and Cao, Jianming and Zhou, Tieli},
  title = {Antimicrobial peptide Hs02 with rapid bactericidal, anti-biofilm, and anti-inflammatory activity against carbapenem-resistant Klebsiella pneumoniae and Escherichia coli},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01050-24}
}
Kostenlos starten →